MENUNews Archive
Date: 08/08/2012
Date: 07/26/2012
Researchers at the University of Michigan Rogel Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The finding implies a new way to target the behavior of these lethal cells.
Date: 07/20/2012
Blocking IL-6 improved response to breast cancer drug Herceptin, U-M study finds
Written by Nicole Fawcett
Date: 07/17/2012
Written by: Kara Gavin; contact by telephone: 734-764-2220; or [email protected]
Date: 07/16/2012
A new study lead by University of Michigan Rogel Cancer Center researchers, led by lead author Bradley Zebrack, Ph.D., MSW, MPH; shows significant proportions of adolescents and young adult cancer patients are not getting their care needs met.
Date: 07/10/2012
UMSkinCheck tracks skin changes, offers skin check reminders.
Date: 06/20/2012
The information on this page has expired. Learn more about pancreatic cancer treatment and research on our pancreatic cancer webpages.
Date: 06/13/2012
Reshma Jagsi, M.D., D.Phil., associate professor at the University of Michigan Medical School, was lead author of the study that found, after taking specialty, productivity and other factors into consideration, gender disparity still exists among doctors.
Date: 06/05/2012
Over men 1200 men with metastatic, hormone-sensitive prostate cancer were given intermittent androgen-deprivation (AD) therapy after seven months of androgen deprivation. The results show intermittent hormone therapy offers some quality-of-life benefits, but lower overall survival.